Westmount Partners, LLC
Source: SEC Form 13F · as of Mar 2026Westmount Partners, LLC holds 19 biotech & pharma companies tracked by BioSniper, totaling $14.4M in value as of Mar 2026 (SEC Form 13F).
Companies held
19
Total value held
$14.4M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 11,315 | $2.8M |
| ABBVAbbVie Inc. | 12,184 | $2.6M |
| LLYELI LILLY & Co | 2,307 | $2.1M |
| AMGNAMGEN INC | 3,796 | $1.3M |
| IONSIONIS PHARMACEUTICALS INC | 12,961 | $973K |
| BMYBRISTOL MYERS SQUIBB CO | 10,367 | $629K |
| MRKMerck & Co., Inc. | 4,890 | $588K |
| PMPhilip Morris International Inc | 3,511 | $581K |
| CAHCardinal Health Inc. | 2,338 | $494K |
| ABTABBOTT LABORATORIES | 4,440 | $456K |
| GILDGILEAD SCIENCES, INC. | 2,843 | $396K |
| PFEPFIZER INC | 12,598 | $354K |
| ALNYALNYLAM PHARMACEUTICALS, INC. | 1,000 | $331K |
| BBIOBridgeBio Pharma, Inc. | 3,193 | $237K |
| NVSNovartis AG | 1,498 | $229K |
| IDXXIDEXX LABORATORIES INC /DE | 400 | $225K |
| CRBUCaribou Biosciences, Inc. | 19,609 | $37K |
| OPKOPKO HEALTH, INC. | 18,550 | $21K |
| FATEFATE THERAPEUTICS INC | 10,098 | $12K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.